Abstract

Purpose: Retrospectively evaluate the benefits of Goretex in preventing the recurrence of symblepharon in 23 eyes affected by chemical injuries with a minimum follow-up of 12 months.
Methods: All patients who underwent symblepharon lysis surgery following chemical injury with Gore-tex were included. For grade 1, symblepharon, CLAG, or AMG along with Gore-tex was placed; for grades 2 & 3, living-related CLAL or CLAG or SLET or AMG and Gore-tex, depending upon tissue availability. After the fourth week, Gore-tex was removed.
Results: 23 eyes of 22 patients with a median age of 17 years and a median follow-up of 36 months; the interval between onset of symptom and first presentation was nine months. Complete success was achieved in 52.1% of eyes, partial success in 34.7%, and 13.04% failed. Success depended upon the length and breadth of the symblepharon.
Conclusion: It is indeed a novel surgical adjuvant to prevent symblepharon recurrence.